Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

ASH 2015: First-In-Class Myeloma Highlights

This article was originally published in Scrip

Executive Summary

A number of first-in-class products for acute myeloid leukemia and multiple myeloma provided clinical updates during the American Society for Hematology's (ASH) annual meeting, held Dec. 4-8 in Orlando, Florida.

Advertisement

Related Content

Agios, Celgene Target Accelerated Approvals For Precision AML Medicines
Agios Gets $200m Up Front In New Celgene Deal, Regains AG-120 Rights

Topics

Advertisement
UsernamePublicRestriction

Register